Form 4: Axon Enterprise CEO Patrick Smith Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Axon Enterprise's CEO, Patrick W. Smith, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Patrick W. Smith, CEO of Axon Enterprise, Inc., executed stock options and sold shares of common stock on August 30, 2024, and September 3-4, 2024.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted on May 24, 2024.
- On August 30, 2024, Smith exercised options for 105,495 shares at a price of $28.58 and sold 1,308 shares at a weighted average price of $361.4832, 6,555 shares at $362.2049, 9,530 shares at $363.2913, 12,386 shares at $364.2449 and 20,221 shares at $364.9807.
- On September 3, 2024, Smith exercised options for 64,505 shares at a price of $28.58 and sold 28,217 shares at a weighted average price of $355.1497, 2,322 shares at $355.9837, 18,226 shares at $355.9837, 8,766 shares at $356.9595, 5,273 shares at $358.0981, 7,289 shares at $358.8724, 2,076 shares at $359.9085, 2,031 shares at $361.131 and 800 shares at $362.7.
- On September 4, 2024, Smith sold 14,444 shares at a weighted average price of $350.4843, 10,758 shares at $351.4429, 2,874 shares at $353.4932, 8,753 shares at $354.3646, 8,090 shares at $355.2614 and 620 shares at $356.0972.
- Following these transactions, Smith directly owns 2,924,827 shares of Axon Enterprise, Inc.
- The sales were to cover tax liabilities and exercise prices associated with the option exercises.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of Axon Enterprise's CEO.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
- The sales were to cover tax liabilities and exercise prices associated with the option exercises.
Key Dates
| Date | Description |
|---|---|
| 05/24/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 08/30/2024 | Date of first transaction (option exercise and stock sale) |
| 09/03/2024 | Date of second transaction (option exercise and stock sale) |
| 09/04/2024 | Date of third transaction (stock sale) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.